Authors
Alexander James Sperry, James Cruikshank, Huong Hoang, Kato Nicholes, George Edward MacKinnon III, Nashaat Zakaria Gerges, Abhay Singh Chauhan.
Summary
This study aimed to compare Xellia Pharmaceuticals’ Vanco Ready® Vancomycin Injection, a premix, room-temperature stable vancomycin IV formulation, with compounded lyophilized vancomycin in a simulated sterile compounding setting, to assess dispensing time and dosing accuracy.